Searched for
FRENCH PHARMA GIANT
French pharma giant Servier to invest €15 million to launch global single-pill platform 'GATINN' in IndiaFrench pharma group Servier is expanding in India with a €15 million investment to launch GATINN, a global platform for single pill combina...- Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 cr from Indian pharma giantsSanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licens...
- Emmanuel Macron announces 30-billion-euro plan to re-industrialise FranceFrench officials believe that France needs to act rapidly to close the gap and not surrender more ground to emerging powers, notably China.
- GMM Pfaudler buys French firm DDPS’s unit for 6.25 million EurosThe company, which had earlier decided to set up a Greenfield glass-lined equipment production at Hyderabad, said it has entered into an ag...
- GAVIS Pharma LLC looking to exit Bengaluru-based Wintac LtdGavis Pharma LLC is now exploring options to exit its listed Indian arm. Wintac Ltd was not part of the 2015 deal struck between Lupin & Ga...
- Johnson & Johnson may buy electrolyte drink ORS-L for Rs 700 croreBangalore-based Jagdale has renewed a sale process to sell the business under the brand ORS-L with an estimated sales of Rs 100 crore annua...
- Wockhardt clears the debt mess, posts 95% YoY growth in Q1The company's consolidated revenues grew by 35% at Rs 1426 cr as against Rs 1053 cr last year, during the same quarter.
- South Africa-based Adcock Ingram buys Cosme Farma for Rs 480 croreSouth Africa-based drug maker Adcock Ingram has quietly acquired privately-held Cosme Farma for Rs 480 crore, a 13 times premium over Cosme...
- Wockhardt Pharma Q4 sales up, stock soars by 7%Mumbai based Wockhardt Pharma's stock price soared by 7 % at Rs 715 as the company beat the street estimates and posted a healthy Q4 margin...
- Abbott Laboratories in pact with Biocon to develop nutrition productsAbbott Laboratories will collaborate with Bangalore-based Biocon to establish a research and development centre to develop nutrition produc...
- Lehman Brothers withdraws plea against Wockhardt-Danone dealLehman Brothers has withdrawn its winding up petition against India's generic drugmaker Wockhardt Pharma, both parties told Bombay High Cou...
- French pharma giant Sanofi Aventis lines up $300 million for Shantha facility in HyderabadThe company will continue to reduce its reliance on big products such as Plavix, which is the world’s second-best-selling drug with 2010 sa...
- Wockhardt must set deadline to pay bondholders: HCOf the 473 crore that has to be paid to bondholders, Wockhardt has deposited 115 crore with the court.
- GlaxoSmithKline Biologicals in talks to buy BE's vaccine divisionThis division produces and markets a range of paediatric and adult vaccines and has a sizeable market share in the Indian vaccine market.
- Genzyme plans to cut 1000 jobs over next 15 monthsCambridge-based biotechnology company Genzyme, which rejected a $ 18.5 bn takeover offer from French pharma giant Sanofi Aventis, plans to ...
- Dr Reddy's, Elder Pharma and Mankind Pharma to hire 3,000 peopleGrowth plans force pharma companies to hunt for talent. Expansion planned in small towns and rural areas.
- Sanofi-Aventis scans India for acquisitionsSanofi-Aventis which bought companies in Brazil, Mexico, and the home-grown Shanta Biotech this year, has sent a delegation to India to fin...
- Wockhardt taps MNCs to sell Protinex, FarexIn a move to prune its debts, troubled pharma firm Wockhardt is in talks with a few MNCs to sell two of its best-selling brands - Protinex ...
- Consolidation helps foreign pharma majors lead the India rank listMerger and acquisitions in the domestic and international pharma industry are gradually changing the Indian pharma landscape in favour of f...
- Sanofi Aventis-Piramal deal falls through over valuationFrench pharmaceutical giant Sanofi Aventis’ proposed deal to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through...
Load More
